IGF2BP3 and gastric cancer: Targeting IGF2BP3 in gastric cancer HGC-27 cells resulted in a significant downregulation of PKMYT1 expression, highlighting the potential role of the ALKBH5/PKMYT1/IGF2BP3 regulatory signaling pathway in gastric cancer metastasis [125].